Studies have shown that active fund managers routinely underperform the S&P500 index*​

Cogent Biosciences, Inc. (NASDAQ: COGT)

COGT Stock Predictions and Ratings

WSX Rating:
NOT AVAILABLE
WSX Forecast (1yr):
NOT AVAILABLE
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
13%

COGT Stock Analysis

COGT PE Ratio:

COGT PEG Ratio: Not Available

COGT Forward EPS Growth (12 month): 0.00%

COGT PS Ratio:

COGT PSG Ratio:

COGT Forward Revenue Growth (12 month): 400.00%

COGT Articles

No data was found